FDA advisory panel votes in favor of Pfizer RSV vaccine
The Food and Drug Administration’s (FDA) vaccine advisory panel on vaccines voted on Thursday in favor of Pfizer’s RSV vaccine on, which would be the first vaccine to protect against the virus in infants if it receives approval.
The …